JNJ dengue: Around November, the ICMR sought the drug regulator’s nod for phase-3 trials of a vaccine candidate it developed with drugmakers SII and Panacea Biotec

Johnson & Johnson’s dengue antiviral drug shows positive results

Panacea Biotec reports consolidated net profit of Rs 15.70 crore in the September 2022 quarter

Buzzing stocks: Infosys, Angel One, Anand Rathi, AB Money, Mindtree, Sterling & Wilson, Power Grid, BHEL, Tata Power, ITC, Suven Life, Panacea Biotec, Mishtaan Foods

Stocks that will see action on October 13, 2022

Panacea Biotec has bagged orders worth Rs 1,040 crore from the Unicef and Pan American Health Organization.

Panacea Biotec Hits Upper Circuit After Winning Rs 1,000-Crore Vaccine Order

Panacea Biotic shares surged on the bourses-NSE and BSE- after the pharmaceutical firm announced on Monday that it had bagged a long-term supply order from UNICEF and Pan American Health Organisation for supply of its pentavalent vaccine Easyfive-TT.

Panacea Biotec stock spikes on $127.3-million global vaccine orders

Panacea Biotec was locked in 20% upper circuit at Rs 160.80 after the company announced the receipt of long-term supply awards worth $127.30 million (around Rs 1,040 crore) from UNICEF and Pan American Health Organization (PAHO).

Panacea Biotec hits the roof on bagging $127 mn orders from UNICEF, PAHO

The order victory exceeds the small-cap company’s whole market capitalisation of Rs955 crore.

Panacea Biotec rallies ~20% on major order win

Stocks to Watch: Check out the companies making headlines before the opening bell

Buzzing Stocks | TCS, Panacea Biotec, Rategain Travel Tech, and others in news today

​​As per a regulatory filing by the company, Jain , who had been admitted to the Medanta Hospital for the last ten days, died after suffering a cardiac arrest on Friday afternoon. Informing the BSE about his demise, Panacea Biotec said, “Soshil Kumar Jain’s sudden and unexpected passing away will be…

Panacea Biotec founder and chairman Soshil Kumar Jain passes away

The U.S. Food and Drug Administration (USFDA) had inspected the Baddi unit of its subsidiary, Panacea Biotec Pharma Ltd. (PBPL) from May 30 to June 8

U.S. FDA asks Panacea Biotec to take corrective measures at Himachal unit

Panacea Biotec Ltd on Thursday said the US health regulator has asked for further corrective actions at the manufacturing unit of its wholly-owned arm at Baddi in Himachal Pradesh

USFDA asks Panacea Biotec to take corrective measures at Himachal unit

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Panacea Biotec Limited is a health management company. The Company's principal business activity is the manufacture of allopathic pharmaceuticals preparations.